| http://www.w3.org/ns/prov#value | - Company Announces Updated Data From EMPOWER Study ST. PAUL, MN, Jun 22, 2010 (MARKETWIRE via COMTEX News Network) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, today announced that updated clinical results from the Company's VBLOC-DM2 ENABLE (DM2) study will be presented on June 26, 2010 a
|
